Skip to main content
Equibles

Beneficial ownership — 13D / 13G

85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Berkshire Hathaway Inc LEN Lennar Corp 13G 6.2% 3mo
LAZARD ASSET MANAGEMENT LLC ARCO Arcos Dorados Holdings Inc. 13G 18.9% 3mo
MADISON DEARBORN PARTNERS LLC AVEX AEVEX Corp. 13G 49.5% 3mo
ARIEL INVESTMENTS, LLC SPHR Sphere Entertainment Co. 13G/A 5.8% 3mo
CANADA PENSION PLAN INVESTMENT BOARD VIK Viking Holdings Ltd 13G/A 3.5% 3mo
BAKER BROS. ADVISORS LP EWTX Edgewise Therapeutics, Inc. 13G/A 3.4% 3mo
Alyeska Investment Group, L.P. NHP National Healthcare Properties, Inc. 13G 5.75% 3mo
Evan Hafer BRCC BRC Inc. 13G/A 55.8% 3mo
1607 Capital Partners, LLC BKF iShares, Inc. 13G/A 2.61% 3mo
ALLIANCEBERNSTEIN L.P. LNKB LINKBANCORP, Inc. 13G/A 0% 3mo
TCG Crossover GP I, LLC VTGN Vistagen Therapeutics, Inc. 13G/A 6.7% 3mo
AMERIPRISE FINANCIAL INC TRMB Trimble Inc. 13G 5.4% 3mo
VAN ECK ASSOCIATES CORP LEU Centrus Energy Corp 13G/A 8.7% 3mo
ARIEL INVESTMENTS, LLC LIND Lindblad Expeditions Holdings, Inc. 13G/A 4.2% 3mo
Harraden Circle Investments, LLC SAC Safeguard Acquisition Corp. 13G/A 6.19% 3mo
Kynam Capital Management, LP VERA Vera Therapeutics, Inc. 13G/A 4.01% 3mo
ARMISTICE CAPITAL, LLC TRVN Trevena, Inc. 13G 9.91% 3mo
METEORA CAPITAL, LLC ONCH 1RT Acquisition Corp. 13G/A 9.85% 3mo
VAN ECK ASSOCIATES CORP EGO Eldorado Gold Corp 13G/A 7.2% 3mo
Driehaus Capital Management LLC CDNL Cardinal Infrastructure Group Inc. 13G 6.08% 3mo
Matthew Hulsizer ETOR eToro Group Ltd. 13G/A 2.5% 3mo
Insight Holdings Group, LLC HAWK HawkEye 360, Inc. 13G 14.5% 3mo
HIGHBRIDGE CAPITAL MANAGEMENT LLC NSTR NorthStar Earth & Space Enterprises, Inc. 13G 5.9% 3mo
American Century Investment Management, Inc. IMKTA Ingles Markets Inc 13G 5.3% 3mo
TCG Crossover GP II, LLC TNGX Tango Therapeutics, Inc. 13G/A 7% 3mo
Balyasny Asset Management L.P. SKYT SkyWater Technology, LLC 13G 6.35% 3mo
ADAR1 Capital Management, LLC GRCE Grace Therapeutics, Inc. 13G/A 9.9% 3mo
Commodore Capital LP KPTI Karyopharm Therapeutics Inc. 13G/A 0% 3mo
American Century Investment Management, Inc. ONIT Onity Group Inc. 13G 6.5% 3mo
PERCEPTIVE ADVISORS LLC IRD Opus Genetics, Inc. 13G/A 9.99% 3mo
LAZARD ASSET MANAGEMENT LLC BRSL Brightstar Lottery PLC 13G 5.5% 3mo
Karpus Management, Inc. NMP NMP Acquisition Corp. 13G/A 5.32% 3mo
PRICE T ROWE ASSOCIATES INC /MD/ NTRA Natera, Inc. 13G/A 6.3% 3mo
Alyeska Investment Group, L.P. SLMT Solmate Infrastructure PLC 13G/A 6.52% 3mo
RTW INVESTMENTS, LP SYRE Spyre Therapeutics, Inc. 13G/A 4.8% 3mo
STEMPOINT CAPITAL LP XLO Xilio Therapeutics, Inc. 13G/A 9.5% 3mo
T. Rowe Price Investment Management, Inc. PEB Pebblebrook Hotel Trust 13G/A 4.8% 3mo
Polar Asset Management Partners Inc. AACP Apogee Acquisition Corp 13G 7.2% 3mo
Rubric Capital Management LP TSAT Telesat Corp 13G/A 0% 3mo
MMCAP International Inc. SPC MZYX MOZAYYX Acquisition Corp. 13G/A 5.8% 3mo
ORBIMED ADVISORS LLC NPCE NeuroPace Inc 13G/A 4.4% 3mo
T. Rowe Price Investment Management, Inc. SRAD Sportradar Group AG 13G/A 4.6% 3mo
American Century Investment Management, Inc. WERN Werner Enterprises Inc 13G 5.1% 3mo
GOLDMAN SACHS GROUP INC MEVO M Evo Global Acquisition Corp II 13G/A 1.7% 3mo
ARMISTICE CAPITAL, LLC VVOS Vivos Therapeutics, Inc. 13G/A 4.99% 3mo
Sculptor Capital LP APMC AmperCap Acquisition Co 13G/A 5.12% 3mo
American Century Investment Management, Inc. GNTX Gentex Corp 13G 5.2% 3mo
James N. Topper VOR Vor Biopharma Inc. 13G/A 4.2% 3mo
G1 Execution Services, LLC FSLR First Solar, Inc. 13G/A 7% 3mo
BAMCO INC /NY/ CDNA CareDx, Inc. 13G/A 3.75% 3mo